Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyan Salari

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Nature|September 23, 2021
Biologically informed deep neural network for prostate cancer discoveryHaitham A Elmarakeby, Justin Hwang, Rand Arafeh, et al.
BJU International|June 10, 2026
The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) studyHeather H Cheng, Kara N Maxwell, Keyan Salari, et al.
Urologic Oncology|May 19, 2023
Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancerKeyan Salari, Jason Kowitz, Jeffrey Twum-Ampofo, et al.
Cancer Research|September 24, 2009
Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancerIlona N Holcomb, Janet M Young, Ilsa M Coleman, et al.
Nature Genetics|June 28, 2008
ESR1 gene amplification in breast cancer: a common phenomenon?Hugo M Horlings, Anna Bergamaschi, Silje H Nordgard, et al.
JAMA|November 17, 2020
Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and MelanomaSaud H AlDubayan, Jake R Conway, Sabrina Y Camp, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Analysis of evolutionary dynamics and clonal architecture in prostate cancerJake R Conway, Alok K Tewari, Sabrina Y Camp, et al.
The Journal of Urology|March 23, 2023
Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate CancerAdam C Schneider, Thenappan Chandrasekar, Nicholas Bowler, et al.
Plos Genetics|June 7, 2008
Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancerKevin A Kwei, Murali D Bashyam, Jessica Kao, et al.
Urologic Oncology|September 10, 2023
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapyKendrick Yim, Kevin Melnick, Sarah L Mott, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Nature|September 23, 2021
Biologically informed deep neural network for prostate cancer discoveryHaitham A Elmarakeby, Justin Hwang, Rand Arafeh, et al.
BJU International|June 10, 2026
The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) studyHeather H Cheng, Kara N Maxwell, Keyan Salari, et al.
Urologic Oncology|May 19, 2023
Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancerKeyan Salari, Jason Kowitz, Jeffrey Twum-Ampofo, et al.
Cancer Research|September 24, 2009
Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancerIlona N Holcomb, Janet M Young, Ilsa M Coleman, et al.
Nature Genetics|June 28, 2008
ESR1 gene amplification in breast cancer: a common phenomenon?Hugo M Horlings, Anna Bergamaschi, Silje H Nordgard, et al.
JAMA|November 17, 2020
Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and MelanomaSaud H AlDubayan, Jake R Conway, Sabrina Y Camp, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Analysis of evolutionary dynamics and clonal architecture in prostate cancerJake R Conway, Alok K Tewari, Sabrina Y Camp, et al.
The Journal of Urology|March 23, 2023
Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate CancerAdam C Schneider, Thenappan Chandrasekar, Nicholas Bowler, et al.
Plos Genetics|June 7, 2008
Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancerKevin A Kwei, Murali D Bashyam, Jessica Kao, et al.
Urologic Oncology|September 10, 2023
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapyKendrick Yim, Kevin Melnick, Sarah L Mott, et al.
Pageof 7